Ardena Expands Global CDMO Footprint with Acquisition of Catalent’s Somerset Facility

  Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlan...

October 15, 2024 | Tuesday | News
Sherry Shao, Rotating CEO of GenScript, Celebrates MSCI's A Rating for Improved ESG Performance

"The A rating from MSCI is a significant recognition of our improvement in ESG performance," said Sherry Shao, Rotating CEO of GenScript. "We believe that ...

October 14, 2024 | Monday | News
Sandoz Launches First FDA-Approved Generic Paclitaxel for Metastatic Breast Cancer

First FDA-approved abbreviated new drug application (ANDA) to reference medicine Single-dose 100 mg vial for intravenous use, approved for metastatic ...

October 14, 2024 | Monday | News
Aileron Therapeutics Showcases Promising LTI-03 Results for Idiopathic Pulmonary Fibrosis at ICLAF

Aileron Therapeutics,  a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs i...

October 14, 2024 | Monday | News
Pfizer Receives FDA Approval for HYMPAVZI™: A New Treatment for Hemophilia A and B

Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ (marstacimab-hncq) for routine prophylaxis ...

October 14, 2024 | Monday | News
New MammoScreen® AI Enhances Breast Cancer Screening with Comprehensive Workflow Features

New MammoScreen® AI delivers a comprehensive suite of features including breast density and pre-reporting, creating the ultimate ...

October 11, 2024 | Friday | News
Andelyn Biosciences Partners with Hubble Therapeutics to Advance Gene Therapy for Rare Childhood Blindness

 Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been s...

October 11, 2024 | Friday | News
Sutro Biopharma Showcases Proprietary Cell-Free Platform for Next-Generation ADC Development

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage oncology company pioneering the development of site-specific and novel-format antibody-drug conjug...

October 11, 2024 | Friday | News
Merck Opens €290 Million State-of-the-Art Biosafety Testing Facility in Maryland, Accelerating Global Drug Development

Note: Merck operates as MilliporeSigma in North America.   Facility consolidates biosafety testing, analytical development, and cell bank manufact...

October 10, 2024 | Thursday | News
Roche Survey Reveals Half of Global Respondents Unaware of HPV’s Link to Cervical Cancer, Urging Immediate Action

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with ne...

October 08, 2024 | Tuesday | Reports
PROCEPT BioRobotics Launches FDA-Approved Trial Comparing Aquablation to Prostatectomy for Cancer Treatment

A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of Aquablation Therapy in Men with Grade Group 1 to 3 Localized Prostate C...

October 08, 2024 | Tuesday | News
Regor Sells Next-Gen CDK Inhibitors to Genentech in $850 Million Deal

Genentech will acquire Regor's next-generation CDK inhibitors for an upfront payment of $850 million in cash. Regor ...

October 07, 2024 | Monday | News
Eli Lilly Invests $4.5 Billion in Medicine Foundry to Transform Drug Development and Manufacturing in Indiana

Indiana facility will combine research, manufacturing and the latest technology to innovate new production methods and scale glo...

October 07, 2024 | Monday | News
Renaissance Lakewood Begins U.S. Manufacturing of FDA-Approved neffy®, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis

Renaissance Lakewood, LLC (“Renaissance”), a leading global contract development and manufacturing organization (“CDMO”) is proud...

October 04, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close